Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Divalproex sodium can unexpectedly cause agitation and hyperactivity in some patients.

A reliable method was created to measure dutasteride and related molecules in capsules.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Dutasteride is more effective than finasteride for hair growth with similar side effects.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

The new compound may be a safer alternative to finasteride for prostate protection.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

Man experienced post-finasteride syndrome symptoms after using finasteride and dutasteride for hair loss.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Clofazimine may be effective for treating ashy dermatosis.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

The FDA rejected a testosterone drug again due to safety concerns.

Health warnings and public health actions led to a significant drop in flutamide prescriptions for women, but off-label use still continues.